Impact of the Nutritional Product PTM202 on Acute and Long-Term Recovery From Childhood Diarrheal Disease

Inclusion Criteria: * Subject's parent or legal guardian is willing and able to give informed consent for participation in the trial. * Male or Female, aged 6 months to 35 months. * Presenting to care for acute diarrhea of 72 hours duration or less at the time of enrollment. * Greater than 3 liquid stools in the previous 24 hours. * In the Investigator's opinion, is able and willing to comply with all trial requirements. * Additional inclusion for Arm 1: in addition to above, the subject will require or have already required \> 8 hours of active rehydration in hospital or ER diarrheal ward, as determined by the attending physician. * Additional inclusion for Arm 2: in addition to above, the subject will require or have already required \< 8 hours of active rehydration in hospital or ER diarrheal ward, as determined by the attending physician. Exclusion Criteria: * Clinical condition for which oral intake of test product or placebo is contraindicated in opinion or attending physician. * History of hypersensitivity or adverse reaction to milk or egg products. * Condition improving in last 24 hours per parental report. * Mild disease severity, defined as no recommended period of observed rehydration therapy per attending physician. * Bloody Diarrhea at presentation. * Severe malnutrition, defined as weight-for-age Z-score \< -3 from median WHO published norms. * Major congenital defects or serious chronic illness (neurologic, pulmonary, gastrointestinal liver, renal or endocr…